About Autoimmune Pulmonary Alveolar Proteinosis (aPAP) aPAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Surfactant consists of proteins and ...

Alveolar-capillary membrane Ground zero for pulmonary edema, Peddle said, is the alveolar-capillary membrane. This vital partition allows gas exchange between the capillaries and alveoli while ...

Negative pressure pulmonary edema (NPPE) is a form of non-cardiogenic pulmonary edema triggered by a swift increase in negative intrapleural pressure due to upper airway obstruction and represents a ...

More information: James B. Grotberg et al, Computational pulmonary edema: A microvascular model of alveolar capillary and interstitial flow, APL Bioengineering (2022).

Those that suffer from more severe COVID-19 with extensive lung damage go on to develop pulmonary fibrosis – which is the unsuccessful reconstruction of damaged alveolar epithelium and the ...

Idiopathic pulmonary fibrosis (IPF) affects 200 000 patients in the United States of America. IPF is responsible for changes in the micro-architecture of the lung parenchyma, such as thickening of the ...

The condition, otherwise known as acute lung injury, adult respiratory distress syndrome, increased-permeability pulmonary edema, and noncardiogenic pulmonary edema, is often a complication of ...

Raising the alveolar PO2, or partial oxygen level, decreases pulmonary artery pressure, leading to resolution of the alveolar and interstitial edema and complete recovery within hours to a few days.